论文部分内容阅读
目的探讨米非司酮治疗育龄妇女子宫腺肌病的临床效果,并观察其对内分泌的影响。方法 2006年3月~2008年9月我院对27例子宫腺肌病患者应用米非司酮治疗,10mg 1日1次口服,连用三个月,治疗前后观察月经量、痛经、子宫体积大小变化,结果27例患者在服药期间均闭经,痛经缓解率为100%,子宫体积缩小平均为51.5%。结论米非司酮治疗子宫腺肌病安全有效。
Objective To investigate the clinical efficacy of mifepristone in the treatment of adenomyosis in women of childbearing age and observe its effect on endocrine. Methods From March 2006 to September 2008, 27 cases of adenomyosis were treated with mifepristone in our hospital. Oral administration of 10mg was given once daily for three months. The menstrual flow, dysmenorrhea, the size of the uterus were observed before and after treatment Changes, the results of 27 patients during amenorrhea, dysmenorrhea relief rate was 100%, the average reduction of uterine volume was 51.5%. Conclusion Mifepristone is safe and effective in the treatment of adenomyosis.